[go: up one dir, main page]

GB201506052D0 - Movement disorder - Google Patents

Movement disorder

Info

Publication number
GB201506052D0
GB201506052D0 GBGB1506052.8A GB201506052A GB201506052D0 GB 201506052 D0 GB201506052 D0 GB 201506052D0 GB 201506052 A GB201506052 A GB 201506052A GB 201506052 D0 GB201506052 D0 GB 201506052D0
Authority
GB
United Kingdom
Prior art keywords
movement disorder
disorder
movement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1506052.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Renishaw PLC
Original Assignee
Renishaw PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renishaw PLC filed Critical Renishaw PLC
Priority to GBGB1506052.8A priority Critical patent/GB201506052D0/en
Publication of GB201506052D0 publication Critical patent/GB201506052D0/en
Priority to US15/095,722 priority patent/US10130814B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36067—Movement disorders, e.g. tremor or Parkinson disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128—Control systems
    • A61N1/36146—Control systems specified by the stimulation parameters
    • A61N1/36182—Direction of the electrical field, e.g. with sleeve around stimulating electrode
    • A61N1/36185—Selection of the electrode configuration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0526—Head electrodes
    • A61N1/0529—Electrodes for brain stimulation
    • A61N1/0534—Electrodes for deep brain stimulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Electrotherapy Devices (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
GBGB1506052.8A 2015-04-09 2015-04-09 Movement disorder Ceased GB201506052D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1506052.8A GB201506052D0 (en) 2015-04-09 2015-04-09 Movement disorder
US15/095,722 US10130814B2 (en) 2015-04-09 2016-04-11 Movement disorder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1506052.8A GB201506052D0 (en) 2015-04-09 2015-04-09 Movement disorder

Publications (1)

Publication Number Publication Date
GB201506052D0 true GB201506052D0 (en) 2015-05-27

Family

ID=53333546

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1506052.8A Ceased GB201506052D0 (en) 2015-04-09 2015-04-09 Movement disorder

Country Status (2)

Country Link
US (1) US10130814B2 (en)
GB (1) GB201506052D0 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX345890B (en) 2008-10-01 2017-02-22 Hua Sherwin System and method for wire-guided pedicle screw stabilization of spinal vertebrae.
US9919146B2 (en) 2013-05-01 2018-03-20 Sherwin Hua Methods and systems for intraventricular brain stimulation
US10369329B2 (en) 2014-01-30 2019-08-06 Renishaw Plc Neurosurgical apparatus and method
US11759629B2 (en) * 2021-02-26 2023-09-19 Sensoria Therapeutics, Inc. Unidirectional electrode and method for stimulation of the subthalamic nucleus of the brain
EP4337119A1 (en) 2021-05-12 2024-03-20 Spine23 Inc. Systems and methods for pedicle screw stabilization of spinal vertebrae
WO2025034993A1 (en) * 2023-08-08 2025-02-13 The Regents Of The University Of California Movement-responsive adaptive deep brain stimulation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993006116A1 (en) 1991-09-20 1993-04-01 Syntex-Synergen Neuroscience Joint Venture Glial derived neurotrophic factor
US6042579A (en) 1997-04-30 2000-03-28 Medtronic, Inc. Techniques for treating neurodegenerative disorders by infusion of nerve growth factors into the brain
US7974696B1 (en) * 1998-08-05 2011-07-05 Dilorenzo Biomedical, Llc Closed-loop autonomic neuromodulation for optimal control of neurological and metabolic disease
US9113801B2 (en) 1998-08-05 2015-08-25 Cyberonics, Inc. Methods and systems for continuous EEG monitoring
US6348050B1 (en) 1999-04-30 2002-02-19 Medtronic, Inc. Infusion systems for creating microenvironments in a living body
GB9928248D0 (en) 1999-12-01 2000-01-26 Gill Steven S An implantable guide tube for neurosurgery
US7981863B2 (en) 2001-09-19 2011-07-19 Neuronova Ab Treatment of Parkinson's disease with PDGF
GB0205772D0 (en) 2002-03-12 2002-04-24 Gill Steven S Catheter
GB2414934A (en) 2004-06-11 2005-12-14 Gill Steven Streatfield Treatment of Parkinson's disease with GDNF
GB0623395D0 (en) 2006-11-23 2007-01-03 Renishaw Plc Port
DE102007007985B4 (en) 2007-02-17 2009-06-10 ESM Ennepetaler Schneid- und Mähtechnik GmbH & Co KG Cutting unit for cutting stalky clippings
US9320914B2 (en) * 2008-03-03 2016-04-26 DePuy Synthes Products, Inc. Endoscopic delivery of red/NIR light to the subventricular zone
CA2879770C (en) 2012-07-24 2021-03-02 Renishaw Plc Neurosurgical apparatus and methods
WO2015149170A1 (en) * 2014-03-31 2015-10-08 Functional Neuromodulation, Inc. Systems and methods for determining a trajectory for a brain stimulation lead

Also Published As

Publication number Publication date
US20160331971A1 (en) 2016-11-17
US10130814B2 (en) 2018-11-20

Similar Documents

Publication Publication Date Title
DK3389557T3 (en) Transseptalt leveringssystem
DK3320033T3 (en) Polyethylenterephthalat-depolymerisering
DK3256579T3 (en) Cysteinprotease
DK3256580T3 (en) Cysteinprotease
DK3298030T5 (en) Anti-cancerfusionspolypeptid
DK3250592T3 (en) Anti-transthyretin-antistoffer
DK3373882T3 (en) Patientisolator
GB201500806D0 (en) Aerosol-gnerating aticle
DK3284069T3 (en) Pos-terminal
DK3390996T3 (en) Trykbart tids-temperaturindikatorsystem
HK1254891A1 (en) Movement between multiple views
DK3380145T3 (en) Injektionsapparat
DK3336185T3 (en) Antistof
DK3272750T3 (en) Morphinan-derivat
HK1251001A1 (en) Il-37 variants
DK3324768T3 (en) Tørdragt
GB201506052D0 (en) Movement disorder
AU361999S (en) Ballustrade
DK3133099T3 (en) Polymermodificeret polyoldispersion
DK3282866T3 (en) Proteinfibre
DK3250312T3 (en) Urea-metalnitrat-scr-system
DK3294653T3 (en) Justerbar inline-port
GB201502316D0 (en) Bitcon technology
GB201502073D0 (en) HDEG technology
DK3242882T3 (en) Cgrp-antagonistpeptider

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)